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ABSORPTION OF SOME ORGANIC COlVIPOUND THR UGH THE 
SKIN IN JVIAN* 
ROBERT J. FELDMANN, M.D. A~D H OvVARD I. MAIBACH, M.D. 
ABSTRA T 
We studied the percutaneous penetration of 21 organic chemicals. The experimental 
m thod consi ted of the application of the chemical to the human forearm and quanti-
tating it penetration th rough the kin by its appearance in urine. 
There was a great diversity in the ability of the chemicals to p nctrate human kin. 
Compounds such as hippuric acid, nicotinic acid, and nitrobenzene support the gen-
erally held view of the excellent chemical barrier properties for them. 
Closely related compound bowed great diff renee in penetration. B nzoic ac id was 
absorbed at 200 time the amount of it gl:cin conjuO'ate-hip1 uric acid. -icoti.nic 
acid barely penetrated; 10% of its amide, nicotinamide, penetrated. Thi u 0' t that 
molecules may be tailored to decrea e or increa e pen tration a n eel d for the mo t 
Nuitable biological function. 
Vve previously characterized the percutaneous 
penetration of a series of teroids in man (1). 
Thi tudy extend t hese ob ervationn using 
the arne experin1ental method to everal other 
simple organic chemical . The method con i t 
of the application of the chemical to the hu-
man fo rearm and quantitatinO' its pen tration 
through the skin by measurinO' it metabolites 
in urine. For analytic convenience, all tudies 
were performed with radiolabeled C4C) tracer 
doses . Measurement was made of the isotope 
only. 
Tbi tudy demon trate diver e re istance to 
the penetration of the e chemicaJ . Compounds 
such a hippuric acid, nicot inic acid and nitro-
benzene upport the generally held view of 
the effective barrier propertie. of the kin; 
others such a dinitrochlorobenzene (DNCB), 
caffeine and benzoic acid penetrate so exten-
sively as to suggest that the human skin has 
little barrier properties to them. 
METHODS Al."D MATERIALS 
Methods of application of the chemical to the 
kin and analysis of radioactivity are those re-
ported in the study of steroid hormones (1, 2) . A 
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compound to be studied must have a significant 
part of its metabolites excreted in urine. B using 
carbon14 labeled tracers, it i possibl to measur 
excretion rat in urin without identification and 
measurement of individual metabolites. Correction 
for incomplet renal excretion must be mad . 
elected compound were parenterally admini -
ter d and the proportion of the carbonu recover-
able in urine d termined. Ten compounds wer 
thus given in ravenously in man. Three pos ibly 
toxic compounds were aiven intraperitoneally to 
guinea pigs. Compound not tested for incomplete 
urine excretion are closely related to compounds 
tc ted or are known to be nearly entirely excreted 
m unne. 
In all experiments the amount of chemical ap-
pli d wa 4 microgram / cm2• The anatomic site 
" ·a th ventral surface of the forearm. For ac-
curate mensuremC'nt. the chemical was di olv d in 
ac tone and applied to a marked area with a micro-
liter s~Tinge. The standard method was to apply a 
4 mirro~n·am / cm2 do e with one microcurie to a 
13 cm2 circular area. When the specific radioac-
tivitv of the ch mical was too low to obtain the 
de it·ed chemical concentration, the ar a wa in-
crea ed . "here the specific activity was high , car-
rier compound wa add d. 
The . kin sites were not protected. The subject 
were a ked not to wash the area for 24 hours. All 
urine was collected for 5 days. The carbonu was 
measured in individual specimens by a m thod 
prcviou ly described (2). This consisted of wet 
a hing 5 rnl of urine with subsequent trappings of 
the C14 C02 with ethanolamine. This was added 
to a cintillator fluid and rount d with appropriate 
standards in a Beckman liquid scintillation counter. 
RE ULTS 
Excretion kinetics (Intravenous control ) . 
T able I how the total excretion of 10 com-
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TABLE I 
14 r covery in urine after i.v. administration 
Compound % Recovered Half life 
aff eiue 59 .4 6 hrs. 
hloramphenicol 67. 4 6 hrs. 
olchi in 27.9 4 hrs. 
Di thyltoluamide 52 .3 4 hrs. 
]) i nit rochlorobenzene 64.0 4 hrs . 
H exachlorophene 4 .4 48 hr . 
i t robenzene 60 .5 20 hrs. 
Pota si um th iocyanate 10 .2 12 hr . 
'alirylir arid 89. 4 hrs. 
r n. 71.7 hr . 
TABLE II 
14 recove1·y in urine after i.v . administration 
in guinea pigs 
Compound % Recovered Half life 
Buttery llow 5 .6 6 hrs. 
Malathion 76.0 4 hrs. 
MeLhylcholanthrene 1 . 2 14 hr . 
pound after intravenous administration in 
man. 
Thre compounds, po sibly too toxic to test 
int rav enou ly in man, were admini tered in-
t ra peritoneally to guinea pig . The re ults are 
in Table II. Nicotinic acid, nicotinamide, hip-
puric acid and phenol were a sumed to have 
a imilar renal excretion pattern to salicylic 
acid . Thiourea ,va ausumed to behave like 
urea. 
Topical administration. Table III gives the 
C14 recovery rate data after topical adminis-
tration for each t ime period and the number of 
ubject , total recovery (in o/o of the applied 
dose) and standard deviation . 
Figure 1 giYes the total 5 day ab orption 
expre ed as o/o of t he applied dose. These are 
li ted in order of magnitude. Absorption of 
greater than 40% was noted with DNCB, 
caffeine and benzoic acid . Nicotinic acid, hip-
puric acid, and t hiourea penetrated in a quan-
tity less than 1% of the applied dose. The rate 
of penetration differed m each collection 
TABLE III 
Abso1·ption after topical administration 
Absorption ra te (% Dose/ hr.) Total absorption 
teroid Time (hrs) 
%of dose S.D. II of subj. 
o-12 12-24 24- 48 48-72 72-96 96-120 
--
eet.\' IRalirylic aeid .141 .43 .334 .147 .076 .060 21.81 3.11 3 
Benzoic aeid 3 .03() .340 .055 .000 .000 .000 42.62 16.45 6 
Buller yellow .215 .o 5 .289 .083 .054 .022 21.57 4.88 4 
afie ine 
.559 1. 38-:J. . 55 .109 .032 .014 47.56 20.99 12 
hloramphenirol .007 .019 .021 .022 .015 .012 2.0-:J. 2.46 6 
Colrhieine .03() .03 .033 .040 .025 .004 3.69 2.50 6 
]) i ni I roc hlorobenzene 3.450 .565 . 134 .045 .01 .009 53 .14 12.41 4 
D .irt hyltolu arnide . 7i3 .331 .0 4 .036 .016 .012 16. 71 5 .10 4 
I xachlorophene .029 .031 .020 .02 .034 .030 3.10 1.09 7 
Hippuric acid .005 .003 .001 .001 .001 .001 .21 . . 09 7 
Malathion 
.313 .170 .044 .017 .011 .006 7. 4 2.71 7 
M thylcholanthrene .062 .329 .25 . 127 .064 .045 16. 1 5 .16 3 
icotinic acid .000 .002 .001 .001 .002 .007 .34 .09 3 
icotinamid 
.019 . 16 .177 .0 .052 .031 11.0 6. 17 7 
itrob nz n .022 .022 .013 .013 .011 .()06 1.53 .84 6 
P araamin b nzoic acid .159 .64 .444 .196 .05 .044 28.37 2 .43 13 
Phenol 
.254 .091 .010 .601 .000 .000 4 .40 2.43 3 
P ota ·~ium thioc 'anate .051 .060 .07 .097 .100 .093 10 .15 6.60 6 
"alicylic acid .116 .535 .356 .156 .0 0 .033 22.7 13.25 17 
Thiour a 
.046 .035 .010 .00 .007 .007 .22 3 
r a 
.021 .051 .073 .075 .034 5.99 1. 91 4 
ABSORPTION OF ORGANIC COMPOU TDS 
COMPOUND 
DINITROCHLOROBENZENE 
CAFFEINE 
BENZOIC ACID 
p-AMINOBENZOIC ACID 
SALICYLIC ACID 
ACETYLSALICYLIC ACID 
BUTTER YELLOW 
METHYL CHOLANTHRENE 
DIETHYL TOLUAMIDE 
NICOTINAMIDE 
POTASSIUM THIOCYANATE 
MALATHION 
UREA 
PHENO~ 
COLCHICINE 
HEXACHLOROPHENE 
CHLORAMPHENICOL 
NITROBENZENE 
THIOUREA 
NICOTINIC ACID 
HIPPURIC ACID 
TOTAL ABSORPTION (% of applied dose) 
.. 
-
-
-• 
I 
I 
0 fO 2b 3b 4b ~ 6o 
" 
Fro. 1. The total absorption of % in applied dose. The forearm was the test site. The e 
data represent the amount of isotope present in urine in the five days after cutaneous appli-
cation. The applied dose was 4 ,ugm/cm2 • 
COMPOUND 
DINITROCHLOROBENZENE 
CAFFEINE 
BENZOIC ACID 
p-AMINOBENZOIC ACID 
SALICYLIC ACID 
ACETYLSALICYLIC ACID 
BUTTER YELLOW 
METHYLCHOLANTHRENE 
DIETHYL TOLUAMIDE 
NICOTINAMIDE 
POTASSIUM THIOCYANATE 
MALATHION 
UREA 
PHENOL 
.. 
COLCHICINE 
HEXACHLOROPHENE 
CHLORAMPHENICOL 
NITROBENZENE 
THIOUREA 
NICOTINIC ACID 
HIPPURIC ACID 
MAXIMUM ABSORPTION RATE (% of apPied dose/hr.) 
Fra. 2. This represents the maximum absorption rate in % of the applied dose/ hour. The 
chemicals are listed in the same order as in Figure 1. K ote the several di crepancie in com-
pounds having a different ranking between highest total absorption and maximum absorp-
tion rate. 
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Fw. 3. This figures demonstrates the abso rption rate in % of the applied dose/hour for 
th mor xt nsively absorbed compounds for several days after cutan ous apphcation. 
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Fw . 4. Thi :fiaure demonstrates the absorption rate in % of the applied dose/ hour for 
additional compounds having a lower absorp tion rate than those in Figure 3. Note the scale 
change from that in Figure 3. 
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Fw. 5. This is the absorption rate in % of the applied dose/hour for addi ional com-
pounds. Caffeine and DNCB are repeated for comparison. Note the scale change from Fig-
ure 3. 
period. The maximum absorption rate ob erved 
for each compound is hown in FiO'ure 2 ill the 
... arne order of compounds a listed in Figure 1. 
Total abNorption depends on both rate of 
ab orption and duration of skin exposure. Th 
di crepancy in order of magnitude in Figures 
1 and 2 may be some a ·pect involving expo ure 
to the compound. Example relatmO' ab orption 
ra e at different time in the experiment are 
given in FiO'ure 3, 4, and 5. The scaleN arc 
different in the three fiO'ure:'. ~ alic~·lic acid wa 
included in Figures 3 and 4 for comparison. 
DISC SSION 
There wa a very larcre difference in pene-
tration of the compounds te ted. The range for 
total ab ·orption was O'reater than 250 times 
,,·bile cliff renee in maximum ab orption rate 
'"ere O'reater than 1000 fold. The total penetra-
tion of benzoic acid, caff ine, and DXCB were 
con ·iderably O'reater than an teroid we tudied 
( 1). 
The great difference in the total quantitie 
and rate. of absorption of the compound listed 
i- a matter of practical importan e. Benzoic acid, 
alicylic acid and phenol are used in topical der-
matological therapy. Butter yellow is an azo dye 
which i not used itself for derrnatologic or cos-
metic purposes, but is related to azo dyes which 
are. E ter of p-aminob nzoic acid are widely 
u:::ed in unscre n preparation .. Diethyltoluamide 
j the mo-t crencrally employed in ect r pell nt. 
1\IIethylcholanthrene and malathion are ex-
ample of toxic sub tances to which there is a 
dnnger of environmental exposure. Almost half 
of the compounds had an absorption greater 
than 20% of the applied do e. 
Two examples are included of closely related 
compound- hawing great differences in pen -
tration. Benzoic acid was absorbed 200 times 
rnor than itN O'lycine conjugate-hippuric acid. 
Nicotinic acid showed minimal penetration 
while 10o/t of it. amide, nicotmamide, was ab-
orbed. It is pas ible that similar difference 
occur in other related chemicals which ar 
applied topically for dermatologic purposes, or 
are encountered in industrial or other environ-
ment . Very few chemical are completely non-
toxic, particularly when parenterally adminis-
tered. 
The total absorption of any chemical will 
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depend on other factors than the permeabil-
ity mea ured in this experiment. No chemical 
shows complete absorption. Presumably the 
balance is lost from the epidermal surface. 
With most compounds the surface loss rate 
must exceed the absorption rate, for the latter 
are generally below 50%. We are impressed by 
the slowness of the penetration of some of 
these compounds. We assume that these long 
periods of penetration represent some storage 
phenomenon; we do not know where this resides 
or its mechanism. Other factors are the ana-
tomic area, the area of exposure, temperature, 
humidity, and the presence of di ease (3). 
Analysis of these data allows a comparison 
of the total penetration of a compound and 
the maximum absorption rate in o/o of the 
applied dose/hour. In Figure 1 the chemicals 
are listed in order of greatest total penetration 
(from the greatest, DNCB, to the least, hip-
puric acid). Figure 2 gives the data in maxi-
mum absorption rate/hour (rather than the 
total absorption) . The same listing arrange-
ment holds in Figure 2. We note that the 
general ranking from greatest to least is simi-
lar but with some exceptions. Caffeine has a 
higher rank in total penetration than in maxi-
mal ab orption rate. Benzoic acid, butter 
yellow and diethyltoluamide represent similar 
exceptions in that their maximal absorption 
rates are somewhat out of line with their total 
ab orption. The mechanism for these differences 
requires explanation. Yet there i generally a 
good correlation bet\veen the maximum pene-
tration rates and the total absorption. 
everal of the e compounds have been stud-
ied previously by others. The published data 
may not reliably be compared with this in vivo 
human experience as in the literature a variety 
of test systems were employed. These included 
in vitro and in vivo models and several species 
from mice to men. In fact, the preMent data 
repre ent the first uch in vivo study in man 
with a large vari ty of compounds. N everthe-
le , certain compari ons seem in order. 
Nicotinic acid was applied to human kin 
in vitro by ron in and touo-hton ( 4). They 
noted no penetration in everal specimens and 
an av rage of 0.001 of the applied dose in 
other specimens. Our in vivo data also suggest 
that it is a minimal penetrant. 
While there have been extensive studies on 
esters of salicylic acid, few investigators ex-
amined the parent compound. Gemmell and 
Morri on measured salicylate blood levels in 
rabbits following applications of 5% salicylic 
acid in 3 ointment vehicles ( 5). Burckhard, 
Wirth and Ganzoni measured urinary salicy-
lates from 10% salicylic acid ointments (6). 
Stolar and associates recorded blood levels in 
rabbits after application of a 6% ointment (7). 
C14 labeled salicylic acid was u ed by Gstirner 
and Elser to mea ure re. idues of ointment 
containing 5% salicylic acid on rabbit skin 
(8). Two recent deaths have been reported 
after whole body application of salicylic acid 
in the treatment of tinea umbricata (9). Al-
though the experimental methods employed dif-
fered from those in this paper, all data sug-
gest the compound is well absorbed. 
We appreciate the cooperation and assistance of 
Drs. Lester Pope and Eugene Prout of the Cali-
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